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Summary
Autosomal recessive spastic ataxia of Charlevoix-Sague-
nay (ARSACS) is a clinically homogeneous form of
early-onset familial spastic ataxia with prominent my-
elinated retinal nerve fibers.More than 300 patients have
been identified, and most of their families originated in
the Charlevoix-Saguenay region of northeastern Que-
bec, where the carrier prevalence has been estimated to
be 1/22. Consistent with the hypothesis of a founder
effect, we observed excess shared homozygosity at
13q11, among patients in a genomewide scan of 12 fam-
ilies. Analysis of 19 pedigrees demonstrated very tight
linkage between the ARSACS locus and an intragenic
polymorphism of the g-sarcoglycan (SGCG) gene, but
genomic DNA sequence analysis of all eight exons of
SGCG revealed no disease-causing mutation. On the ba-
sis of haplotypes composed of seven marker loci that
spanned 11.1 cM, the most likely position of the AR-
SACS locus was 0.42 cM distal to the SGCG polymor-
phism. Two groups of ARSACS-associated haplotypes
were identified: a large group that carries a common
SGCG allele and a small group that carries a rare SGCG
allele. The haplotype groups do not appear to be closely
related. Therefore, although chromosomes within each
haplotype group may harbor a single ARSACS mutation
identical by descent, the two mutations could have in-
dependent origins.
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Introduction
Patients with autosomal recessive spastic ataxia of Char-
levoix-Saguenay (ARSACS [MIM 270550]) present in
early childhood with spastic gait ataxia. The disease pro-
gresses rapidly in young adults, and patients are wheel-
chair bound by their 5th decade. Hypermyelinated
retinal nerve fibers are a unique diagnostic feature (Bou-
chard 1991). Sensory-nerve conduction is abolished, and
motor-nerve velocity is reduced (Bouchard et al. 1979).
Magnetic-resonance images show cerebellar vermis at-
rophy, and autopsy studies reveal both the absence of
Purkinje cells (Bouchard 1991) and the presence of swol-
len neurons with dense, lipofuscin-like granules (Richter
et al. 1996). The hypermyelinated retinal fibers and the
hypoplasia of the superior cerebellar vermis point to
developmental defects in myelination of the central and
peripheral nervous systems in ARSACS, whereas the
progressive axonal degeneration in the corticospinal and
spinocerebellar tracts accounts for the peripheral clinical
signs (Harding 1993).
Families with ARSACS originate from the population,
of French descent, of Charlevoix County and the Sague-
nay–Lac St. Jean region of northeastern Quebec (here-
after we will refer to Saguenay-Lac St. Jean as “Sague-
nay”). In the Saguenay population, for the period
1941–85, the incidence of ARSACS has been estimated
to be 1/1,932 births, and the carrier prevalence has been
estimated to be 1/22; the relatively high incidence has
been attributed to founder effect (De Braekeleer et al.
1993). There are relatively high incidences of several
Mendelian diseases in the Charlevoix-Saguenay popu-
lation (see Bouchard and De Braekeleer 1991).
Recently, we reported that the ARSACS locus maps
to chromosome region 13q11 and that the candidate
region appears to be 5.5 cM, by inspection of haplotypes
in recombinant individuals (Bouchard et al. 1998). Sub-
sequently, we constructed a genetic map of the region,
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on the basis of combined linkage and physical mapping
data from both this study and public databases; more
precisely mapped the ARSACS locus by location-score
analysis; and constructed haplotypes to significantly nar-
row the candidate-gene region. We report here the details
of the genetic mapping of the ARSACS locus.
Families and Methods
Families
Over a 20-year period, 1200 ARSACS families in-
cluding 320 patients living in the Charlevoix-Saguenay
region were identified (Bouchard et al. 1978, 1998; Bou-
chard 1991; Richter et al. 1993). The 1997 population
sizes are 30,659 and 296,537 for Charlevoix County
and Saguenay-Lac St. Jean, respectively (Quebec’s Bu-
reau of Statistics). The patients were identified and fol-
lowed in the neuromuscular-disease clinics in Quebec
City (J.-P.B.) and Chicoutimi (J.M.). After informed con-
sent had been obtained, to comply with institutional and
national standards (Knoppers and Laberge 1991), we
collected blood, for DNA extraction and to establish
lymphoblastoid cell lines, from 84 affected individuals
and 316 other relatives from 25 extended families. Ped-
igree information for 12 families has been published else-
where (Richter et al. 1993).
DNA Analysis and Genomewide Scans
DNA was prepared as described elsewhere (Richter et
al. 1993). Eight families (31 patients, 108 individuals)
were studied by means of 121 highly polymorphic mi-
crosatellite markers (distributed approximately every
25–30 cM), by the method of rapid genotyping, at Ge´-
ne´thon (Gyapay et al. 1994). No evidence for linkage
was obtained. A semiautomated, second genomewide
scan was done on 29 patients and 18 parents from 12
families, by a modified version of the Cooperative Hu-
man Linkage Center (CHLC) Human Screening Set (ver-
sion 6.0) of polymorphic markers (Dubovsky et al.
1995). This screening set comprised 298 fluorescently
labeled microsatellite markers (Research Genetics) with
an average heterozygosity of .75 and with an average
spacing of 12 cM between markers. Multiplexed PCR
products were analyzed on an ABI 377 DNA sequencer
(PE Applied Biosystems). Gels were visually inspected
for shared homozygosity among patients, and an in-
crease was noted for the tetranucleotide repeat
CHLC.GATA23C03 (D13S787) located in chromsome
region 13q11 (Genome Database; Cayanis et al. 1998).
Genotyping of Microsatellite Loci in Chromosome
Region 13q11
Nine microsatellite loci (D13S175, D13S1236,
D13S1275, D13S232, D13S292, D13S787, D13S1243,
D13S283, and D13S1285) were typed in 243 individ-
uals, including 76 carrier parents and 69 affected off-
spring, from 19 pedigrees. Nine of the pedigrees were
nuclear families, and the remainder were extended fam-
ilies. The marker alleles were amplified by PCR, with
one of the primers end labeled with [32P]-gATP, under
standard conditions. The PCR products were separated
by electrophoresis on acrylamide-urea sequencing gels
and were visualized by autoradiography. Allele sizes
were determined by means of a sequencing ladder.
Exon Sequencing of the g-Sarcoglycan (SGCG) Gene
Eight DNA samples from obligate carriers were used
to screen for variation in the exons of the SGCG gene,
by comparative sequencing. Specifically, each exon was
amplified from the individual genomic DNA samples, by
means of primers designed by McNally et al. (1996).
The PCR products were purified by the solid-phase
reversible-immobilization procedure (Hawkins et al.
1994), and both strands were sequenced by means of
FS dye primer cycle sequencing kits (PE Applied Biosys-
tems) and then were run on ABI 377 sequencers. The
exonic sequences were aligned by the Staden (GAP4)
package (Staden 1996). We identified two single-nucle-
otide substitutions, CrT transitions, in exon 8, at nu-
cleotide positions 38 and 222 of GenBank accession
number U63395 (McNally et al. 1996). They define sin-
gle-nucleotide polymorphisms (SNPs) that have been re-
ported by McNally et al. (1996). The first SNP is a silent
substitution in a leucine residue (codon 235), and the
second is located in the 3′ UTR, 13 nucleotides beyond
the stop codon. At least one carrier parent and one AR-
SACS offspring from each of 19 nuclear families were
genotyped for both SNPs, by the method described
above.
Genetic Map of Microsatellite Loci in Chromosome
Region 13q11
Genotypes of nine marker loci for eight Centre
d’Etude du Polymorphisme Humain (CEPH) Genotype
Database families were obtained from two sources.
Data for D13S175, D13S1236, D13S1275, D13S292,
D13S1243, D13S283, and D13S1285, were retrieved
from the CEPH Genotype Database (version 8.1), and
data for D13S232 and D13S787 were retrieved from
the Center for Medical Genetics, Marshfield Medical Re-
search Foundation genotype database (Broman et al.
1998). CEPH Genotype Database family data for
D13S787 genotypes that were uncertain (J. Weber, per-
sonal communication) were omitted from the analysis.
In the ARSACS families, D13S175 and D13S1243 were
not typed in one nuclear family and in one large, ex-
tended pedigree.
The order of the nine marker loci was determined on
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the basis of various linkage, physical, and integrated
maps (Chumakov et al. 1995; Guilford et al. 1995; Hud-
son et al. 1995; Shaw et al. 1995; Collins et al. 1996;
Dib et al. 1996, and supplementary material in an ex-
tended reprint; Broman et al. 1998; Cayanis et al. 1998;
authors’ unpublished data). The physical-map order was
given precedence particularly where the local order of
markers was not reliably established on the linkage
maps. The CEPH Genotype Database and ARSACS ped-
igrees were analyzed for linkage between adjacent
marker loci. The LOD scores for the families were com-
bined to obtain maximum-likelihood estimates of re-
combination fraction (v) values.
Two-Point Linkage Analysis
LOD scores for data from genomewide scans were
computed by LINKAGE programs (version 5.1) (La-
throp et al. 1984, 1985). LOD scores and v values both
between adjacent pairs of the nine marker loci and be-
tween each marker and the ARSACS locus were com-
puted by FASTLINK versions (4.0P) (Cottingham et al.
1993; Scha¨ffer et al. 1994; Scha¨ffer 1996) of the LINK-
AGE programs. Marker-allele frequencies in the 19 AR-
SACS pedigrees were estimated by FASTLINK/ILINK,
and linkage equilibrium was assumed (Terwilliger and
Ott 1994). The ARSACS disease-allele frequency was
estimated to be .023, on the basis of a previous genetic
epidemiological study (De Braekeleer et al. 1993), and
complete penetrance of the autosomal recessive trait was
assumed.
Location Scores and Haplotypes of the ARSACS
Candidate-Gene Region
Location-score analysis (Lathrop et al. 1984) and hap-
lotyping were performed by Markov-chain Monte Carlo
methods (Sobel and Lange 1996; Lange 1997, by the
SIMWALK2 program (versions 2.01 and 2.27) (Weeks
et al. 1995; E. Sobel, personal communication), with
computation of the multipoint LOD scores by the MEN-
DEL package (version 3.35) (Lange et al. 1988; Lange
1997). In location-score analysis, the most likely initial
genetic-descent graph (also known as the “inheritance
vector”) of a pedigree was found by simulated annealing
in three parallel runs. Two thousand sampled pedigrees
for each original pedigree were obtained by random
walk from the initial position. These representative ped-
igrees are completely typed and proportional to their
true likelihood. The MENDEL program was used to
compute multipoint LOD scores for the sample of rep-
resentative pedigrees. In haplotyping, the best marker-
haplotype vector for each pedigree was found by sim-
ulated annealing in three parallel runs. Two analyses
were conducted for location scores and haplotypes; both
analyses used the genetic map for the combined CEPH
Genotype Database and ARSACS family data, for seven
of the marker loci (D13S1236, D13S232, D13S1275,
D13S292, D13S787, D13S283, and D13S1285). For
the first analysis, marker-allele frequencies were esti-
mated in the 19 ARSACS pedigrees by maximum like-
lihood, with linkage equilibrium being assumed, and
these frequencies were also used in the two-point linkage
analyses. For the second analysis, marker-allele frequen-
cies were estimated by weighting the conditional allele
frequencies in ARSACS and normal haplotypes of 68
carrier parents by the ARSACS and normal allele fre-
quencies (.023 and .977, respectively) in the population.
The marker haplotypes were constructed by the first
SIMWALK2 analysis and were identified as either AR-
SACS associated or normal, on the basis of cosegregation
with the deduced ARSACS allele, in each of the pedi-
grees. The haplotypes of the 68 obligate carrier parents
obtained in the second SIMWALK2 analysis were used
for further analysis. Alternative estimates of the condi-
tional frequencies of haplotypes were based on 55 dis-
ease-associated and 58 normal chromosomes, obtained
by not counting copies that were considered to be iden-
tical by descent within a pedigree. The conditional fre-
quencies of ARSACS-associated and normal haplotypes
may be representative of the population, although the
families were not selected to constitute a population-
based sample.
Results
In the first genomewide scan of eight multiplex AR-
SACS families, no evidence for linkage was obtained. A
LOD score greater than 2 at was obtainedv  .01–.2
for 121 microsatellite loci (data not shown). The second
genomewide scan of parents and patients from 12 nu-
clear families was undertaken with a different set of mi-
crosatellite markers. Shared homozygosity for D13S787
allele 4 (259 bp) was observed in all the patients except
for those in two nuclear families in which the patients
were heterozygous 3/4 (255 and 259 bp, respectively)
and 4/5 (259 and 262 bp, respectively). There was sig-
nificant evidence for linkage to D13S787 (LOD score
3.66 at ), a result that mapped the ARSACS locusv  0
to chromosome region 13q11. In the first genomewide
scan, chromosome 13q was sparsely covered by three
markers 116 cM distal to D13S787.
To better localize the ARSACS locus, nine microsat-
ellite loci were chosen from the Ge´ne´thon and Marsh-
field linkage maps, and 243 individuals from 19 AR-
SACS pedigrees were genotyped. No recombinants were
observed, by two-point linkage analysis, between AR-
SACS and either D13S232 (maximum LOD score 24.1
at maximum v [ ] 0) or D13S787 (maximum LOD scoreˆv
24.7 at ) (table 1).ˆv  .005
We attempted to obtain a better estimate of the genetic
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Table 1
Two-Point Linkage between ARSACS and Marker Loci in Chromosome Region 13q11
MARKER
LOCUS
LOD SCORE AT v 
MAXIMUM
LOD
SCORE ˆv0 .01 .03 .05 .07 .09 .11
D13S175  4.99 8.75 9.94 10.34 10.36 10.14 10.39 .081
D13S1236  17.97 20.15 20.33 19.89 19.16 18.24 20.36 .043
D13S1275  28.19 27.47 26.25 24.87 23.41 21.92 28.19 .010
D13S232 24.13 23.54 22.35 21.15 19.94 18.73 17.51 24.13 .000
D13S292  19.55 18.95 18.08 17.13 16.14 15.13 19.56 .008
D13S787 24.39 24.61 23.75 22.66 21.49 20.27 19.03 24.69 .005
D13S1243  17.96 19.53 19.47 18.91 18.10 17.15 19.60 .038
D13S283  12.46 12.94 12.73 12.29 11.74 11.12 12.94 .029
D13S1285  12.71 15.86 16.54 16.47 16.03 15.37 16.57 .057
Table 2
Genetic Maps of Marker Loci in Chromosome Region 13q11 in CEPH Genotype Database and ARSACS Families and Combined
Family Data
MARKER LOCUS
GENETIC LOCATION DATABASE
COMPOSITE LOCATION
(Mb)
(MAXIMUM LOD SCORE) INaˆv
MAP DISTANCE,
FOR ALL FAMILIES
(cM)
CEPH Genotype
Database Families ARSACS Families All Families
D13S175 16.201 .037 (12.24) .066 (26.49) .060 (38.57) 0
D13S1236 16.380 .051 (23.23) .028 (44.72) .036 (67.67) 6.4
D13S1275 18.570 .000 (30.67) .005 (45.83) .003 (76.33) 10.1
D13S232 19.141 .022 (23.12) .007 (27.62) .013 (50.55) 10.4
D13S292 19.250 .000 (16.30) .000 (29.50) .000 (45.80) 11.7
D13S787 19.370 .017 (14.96) .039 (32.36) .034 (47.17) 11.8
D13S1243 19.490 .000 (26.19) .029 (25.72) .017 (51.01) 15.4
D13S283 20.490 .018 (29.64) .026 (26.99) .022 (56.59) 17.1
D13S1285 21.080 19.3
NOTE.—For location-score and haplotype analyses, was assigned between D13S292 and D13S787, and wasv  .001 v  .033
estimated for D13S787 and D13S283 (see text).
a The estimates are for adjacent loci and pertain to this locus and that on the line below.
map of this region, for multipoint-linkage and haplotype
analyses. First, the order of published physical maps was
validated by additional physical mapping of YACs and
bacterial artificial chromosomes in our laboratory (data
not shown). Second, we estimated v values between ad-
jacent marker loci by combining the results of linkage
analysis of CEPH Genotype Database family data from
public genotype databases and the results of linkage
analysis of the ARSACS families. The estimated genetic
length of the region spanned by the nine loci, in the
combined family data, was 19.3 cM (table 2). Between
D13S1243 and the flanking loci—D13S787 and
D13S283—there was apparently greater recombination
in the ARSACS families than in the CEPH Genotype
Database families, although the 1-LOD-unit support in-
tervals for the two sets of family data overlapped (data
not shown). Since D13S787, D13S1243, and D13S283
are located on a 1.71-Mb YAC (906_c_1) (CEPH-Ge´-
ne´thon Integrated Map; Chumakov et al. 1995), the
length of our map of the nine marker loci may be over-
estimated. We found it difficult to score D13S1243 gen-
otypes, although we could determine them in nuclear
families such that there were no Mendelian segregation
errors. Therefore, for multipoint mapping and haplotype
analysis of the candidate region of the ARSACS gene,
we chose a subset of seven loci (D13S1236, D13S1275,
D13S232, D13S292, D13S787, D13S283, and
D13S1285) that did not include D13S175 (the most
proximal locus) and D13S1243. We estimated betweenˆv
D13S787 and D13S283 to be .033 (maximum LOD
score 38.5). In addition, no recombination (maximum
LOD score 45.8) was observed between D13S292 and
D13S787, but both loci are located on a 600-kb YAC
(768_a_4) (CEPH-Ge´ne´thon Integrated Map). We ar-
bitrarily assigned to this pair of loci, for lo-v  .001
cation-score and haplotype analyses. Finally, the esti-
mated genetic length of the region spanned by these
seven marker loci is 11.1 cM, under the assumption that
there is no interference (fig. 1).
Location scores were computed for the ARSACS locus
by the SIMWALK2 and MENDEL programs, under the
assumption of linkage equilibrium for two sets of
marker-allele frequencies (fig. 1). The best haplotype vec-
tors for the pedigrees were estimated by SIMWALK2
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Figure 1 Location-score analysis of ARSACS locus. The SIMWALK2 program was used to generate 2,000 sampled pedigrees for each
original pedigree, by Markov-chain Monte Carlo methods. These representative pedigrees are completely typed and proportional to their true
likelihood. The MENDEL program was used in conjunction with SIMWALK2, to compute the multipoint LOD scores (E. Sobel, personal
communication). The run with the larger LOD scores used marker-allele frequencies that were weighted estimates from ARSACS-associated
and normal haplotypes (see Methods); the run with the smaller LOD scores used sample estimates of marker-allele frequencies.
(see below). The linkage analyses will tend to underes-
timate the LOD scores, because linkage disequilibrium
was not taken into account (Clerget-Darpoux 1982). As
in the two-point linkage analysis (table 1), there was no
evidence of recombination between the ARSACS locus
and D13S232. Maximum multipoint LOD scores were
41.0 at positions 4.56 and 4.61 cM distal to D13S1236,
in the first analysis, and 42.3 at positions 4.43 and 4.48
cM, in the second analysis (fig. 1). On the results of the
latter location-score analysis, the most likely position of
the ARSACS locus would be 0.42 cM distal toD13S232.
The 2-LOD-unit support interval for the map position
of the ARSACS locus extends distal to D13S1275 and
proximal to D13S292. Thus, the likely candidate region
for the ARSACS gene has been narrowed 1.58 cM.
We used SIMWALK2 to estimate the seven-marker
haplotypes in the 19 pedigrees. There are two distinct
groups of ARSACS-associated haplotypes: a large group
consisting of 22 haplotypes and a small group consisting
of 2 haplotypes (table 3). In the large group, 14 of 53
chromosomes were inferred to have the same seven-
marker haplotype as a major ancestral haplotype (but
they are not necessarily identical by descent for the entire
11.1-cM region). A core haplotype of the 1.6-cM central
map region (spanned by D13S1275, D13S232,
D13S292, and D13S787) that harbors the ARSACS lo-
cus was shared by 41 of 53 chromosomes in the large
haplotype group. Only 3 of 58 normal chromosomes
carried a core haplotype (2-5-1-3, 2-5-1-4, and 3-5-1-
4) that was present in the ARSACS chromosomes.
On the basis of the genotyping of two SNPs in exon
8 of the SGCG gene in a subset of individuals from 19
nuclear families, all ARSACS-associated haplotypes car-
rying D13S232*5 carried SGCG exon 8 haplotype C-
C (table 4). Furthermore, the rare ARSACS-associated
haplotypes that carried D13S232*2 (table 3) had SGCG
exon 8 haplotype T-C. SGCG exon 8 haplotype C-C
was the most frequent haplotype in both ARSACS chro-
mosomes and normal chromosomes, whereas haplotype
C-T was not observed in the sample of 19 nuclear fam-
ilies, and no particular exon 8 haplotype was absolutely
associated with D13S232 alleles in normal chromo-
somes (table 4).
Discussion
The Quebec population of French descent has its or-
igins in the immigration of 8,527 settlers during
1608–1759 (Charbonneau and Robert 1987). The set-
tlement of the Charlevoix region began in 1675 (Jette´
et al. 1991). During 1838–1911, 13,800 individuals im-
migrated from Charlevoix to Saguenay (Gauvreau et al.
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Table 3
ARSACS-Associated Haplotypes in 55 Parents of ARSACS Patients
ALLELE AT
NO. OF
PARENTS
D13S1236
(.0 cM)
D13S1275
(3.74 cM)
D13S232
(4.04 cM)
D13S292
(5.35 cM)
D13S787
(5.45 cM)
D13S283
(8.87 cM)
D13S1285
(11.12 cM)
1 2 5 1 3 7 8 1
1 2 5 1 4 2 4 1
1 2 5 1 4 6 6 1
1 2 5 1 4 7 7 1
1 2 5 1 4 7 4 3
1 2 5 1 4 7 6 2
1 2 5 1 4 7 8 14
4 2 5 1 4 7 8 8
4 2 5 1 4 7 6 2
2 2 5 1 4 7 8 2
2 2 5 1 4 7 6 1
3 2 5 1 4 7 8 5
5 2 5 1 4 7 8 1
4 2 5 2 4 7 6 2
3 2 5 2 4 7 6 1
4 3 5 1 4 7 6 1
5 3 5 1 4 2 4 1
1 4 5 1 4 7 8 1
3 4 5 1 4 7 8 1
9 6 5 1 4 7 8 2
4 7 5 1 4 7 8 1
2 7 5 1 4 7 6 1
2 3 2 1 5 10 3 1
3 3 2 1 5 1 6 1
Haplotypes for 55 ARSACS and 58 normal chromosomes were obtained from 68 obligate carrier parents
by not counting copies that were considered to be identical by descent within a pedigree. Haplotypes were
inferred for seven parents who were not sampled. Among the 58 normal chromosomes there was one each
of the D13S1275-D13S232-D13S292-D13S787 core haplotypes, 2-5-1-4, 3-5-1-4, and 2-5-1-3; the re-
mainder were different than the ARSACS-associated core haplotypes. The ARSACS locus was estimated
by location-score analysis to be at 4.45 cM with a 2-LOD-unit support interval from 3.78 to 5.35 cM.
1991); therefore, Charlevoix made the major contribu-
tion to the founding of the Saguenay population (Bou-
chard et al. 1988). The genetic epidemiology of ARSACS
indicates that a founder effect occurred in the Charlevoix
population (De Braekeleer et al. 1993).
We computed location scores (fig. 1) and constructed
haplotypes (table 3) for an 11.1-cM region spanned by
seven microsatellite loci in chromosome region 13q11,
using the SIMWALK2 and MENDEL programs. The
ARSACS locus was estimated to be 0.42 cM distal to
D13S232 (multipoint LOD score 42.3; 2-LOD-unit sup-
port interval 1.58 cM). No recombination was observed
between the ARSACS locus and D13S232, and, since
D13S232 is an intragenic polymorphism of SGCG, we
sequenced all eight exons of the latter gene; but we did
not find a disease-causing mutation. The overwhelming
majority of ARSACS chromosomes (53 of 55 chromo-
somes from parents of patients) carried allele
D13S232*5, SGCG-exon 8 C-C (based on a sample of
19 nuclear families), and both of the remaining chro-
mosomes were observed to carry the rare allele
D13S232*2, SGCG-exon 8 T-C. Thus, two groups of
ARSACS-associated haplotypes are minimally defined
by different SGCG alleles: a large group consisting of
22 haplotypes and a small group consisting of 2 hap-
lotypes (table 3). In the large haplotype group, an in-
ferred, major ancestral haplotype, 1-2-5-1-4-7-8, was
present on 14 (26%) of 53 ARSACS chromosomes.
The haplotypes in the large group that contain alleles
D13S292*2 and D13S787*3 are not obviously recom-
binant haplotypes. These alleles may have originated by
mutation on the major ancestral chromosome. Both al-
leles are smaller, by one repeat, than the ARSACS-as-
sociated allele at the corresponding loci. Gain or loss of
a single repeat unit is the predominant mutational event,
as a consequence of replication slippage, of short tan-
dem-repeat sequences (Weber and Wong 1993; Brink-
mann et al. 1998). In any event, these haplotypes do not
further narrow the ARSACS candidate-gene region. The
two chromosomes in the small group of ARSACS-as-
sociated haplotypes appear to be related, since they share
a core haplotype (D13S1275, D13S232, D13S292, and
D13S787) that is distinctly different than the haplotypes
of the large group. However, the most recent common
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Table 4
SGCG Alleles Defined by D13S232 Allele and
Exon 8 SNP Haplotype
D13S232 ALLELE
EXON 8 SNP HAPLOTYPE
(NO. OF CHROMOSOMES)
ARSACSa Normal
1 ) C-C (5)
T-C (1)
T-T (1)
2 T-C (2) C-C (1)
4 ) C-C (1)
T-C (1)
5 C-C (34) C-C (10)
T-C (2)
6 ) C-C (3)
T-C (3)
T-T (2)
7 ) C-C (4)
T-C (2)
a An ellipsis ()) denotes that the allele was not
observed.
ancestral haplotype of the small group is probably not
very recent, since the two haplotypes differ in both flank-
ing regions, most likely as a consequence of recombi-
nation. Our hypothesis is that the overwhelming ma-
jority (96%) of ARSACS chromosomes that carry allele
D13S232*5, SGCG-exon 8 C-C, also harbor the same
disease-associated mutation identical by descent. Fur-
thermore, the remaining (4%) ARSACS chromosomes
that carry rare allele D13S232*2, SGCG-exon 8 T-C,
may harbor another mutation of independent origin.
The ARSACS gene region (defined by the 2-LOD-unit
support interval in the location-score analysis) lies distal
to D13S1275 and proximal to D13S292 and spans 1.58
cM (fig. 1). The Genetic Location Database composite
map distance of this interval is 680 kb (table 2). We
estimated the ARSACS locus to be 0.42 cM distal to
D13S232 and have constructed a BAC contig that in-
cludes SGCG, D13S232, D13S292, and D13S787 and
is 675 kb (J. Engert, T. J. Hudson, and A. Richter,
unpublished data). Excluding the BAC that is positive
for D13S787 reduces the maximum physical size of this
genomic segment to 525 kb, for a search of the ARSACS
gene.
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